A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Zucali, Paolo Andrea; Perrino, Matteo; De Vincenzo, Fabio; Giordano, Laura; Cordua, Nadia; D'Antonio, Federica; Santoro, Armando

Zucali, Paolo Andrea; Perrino, Matteo; De Vincenzo, Fabio; Giordano, Laura; Cordua, Nadia; D'Antonio, Federica; Santoro, Armando.

Afiliação

Zucali PA; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: paolo.zucali@humanitas.it.
Perrino M; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: matteo.perrino@cancercenter.humanitas.it.
De Vincenzo F; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: fabio.de_vincenzo@cancercenter.humanitas.it.
Giordano L; Biostatistic Unit, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: laura.giordano@cancercenter.humanitas.it.
Cordua N; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: nadia.cordua@cancercenter.humanitas.it.
D'Antonio F; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: federica.dantonio@cancercenter.humanitas.it.
Santoro A; Department of Medical Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. Electronic address: armando.santoro@cancercenter.humanitas.it.

Lung Cancer ; 142: 132-137, 2020 04.

Article em En | MEDLINE | ID: mdl-32102735

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Mesotelioma Maligno/tratamento farmacológico; Neoplasias Pleurais/tratamento farmacológico; Terapia de Salvação; Desoxicitidina/administração & dosagem; Desoxicitidina/análogos & derivados; Feminino; Seguimentos; Humanos; Mesilato de Imatinib/administração & dosagem; Masculino; Mesotelioma Maligno/patologia; Pemetrexede/administração & dosagem; Neoplasias Pleurais/patologia; Prognóstico; Taxa de Sobrevida; Gencitabina

Palavras-chave

Combination therapy; Gemcitabine; Imatinib; Mesothelioma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Mesotelioma Maligno Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Lung Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google